232 related articles for article (PubMed ID: 32624540)
1. [Precision medicine and molecular target drugs in pediatric hematologic malignancies: acute lymphoblastic leukemia].
Takita J
Rinsho Ketsueki; 2020; 61(6):657-664. PubMed ID: 32624540
[TBL] [Abstract][Full Text] [Related]
2. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities.
Tran TH; Hunger SP
Semin Cancer Biol; 2022 Sep; 84():144-152. PubMed ID: 33197607
[TBL] [Abstract][Full Text] [Related]
3. [Genetic basis of pediatric T-cell acute lymphoblastic leukemia and its clinical impact].
Takita J
Rinsho Ketsueki; 2018; 59(7):953-959. PubMed ID: 30078808
[TBL] [Abstract][Full Text] [Related]
4. [Genetic and epigenetic aberrations of pediatric leukemia and clinical applications].
Takita J
Rinsho Ketsueki; 2016; 57(10):2294-2300. PubMed ID: 27795542
[TBL] [Abstract][Full Text] [Related]
5. Next-Generation Sequencing in Acute Lymphoblastic Leukemia.
Coccaro N; Anelli L; Zagaria A; Specchia G; Albano F
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31208040
[TBL] [Abstract][Full Text] [Related]
6. Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia.
Liu YF; Wang BY; Zhang WN; Huang JY; Li BS; Zhang M; Jiang L; Li JF; Wang MJ; Dai YJ; Zhang ZG; Wang Q; Kong J; Chen B; Zhu YM; Weng XQ; Shen ZX; Li JM; Wang J; Yan XJ; Li Y; Liang YM; Liu L; Chen XQ; Zhang WG; Yan JS; Hu JD; Shen SH; Chen J; Gu LJ; Pei D; Li Y; Wu G; Zhou X; Ren RB; Cheng C; Yang JJ; Wang KK; Wang SY; Zhang J; Mi JQ; Pui CH; Tang JY; Chen Z; Chen SJ
EBioMedicine; 2016 Jun; 8():173-183. PubMed ID: 27428428
[TBL] [Abstract][Full Text] [Related]
7. Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia-Therapy and Toxicity Mechanisms.
Lejman M; Kuśmierczuk K; Bednarz K; Ostapińska K; Zawitkowska J
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575992
[TBL] [Abstract][Full Text] [Related]
8. Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia.
Heikamp EB; Pui CH
J Pediatr; 2018 Dec; 203():14-24.e2. PubMed ID: 30213460
[No Abstract] [Full Text] [Related]
9. Panel-based next-generation sequencing identifies prognostic and actionable genes in childhood acute lymphoblastic leukemia and is suitable for clinical sequencing.
Ishida H; Iguchi A; Aoe M; Takahashi T; Tamefusa K; Kanamitsu K; Fujiwara K; Washio K; Matsubara T; Tsukahara H; Sanada M; Shimada A
Ann Hematol; 2019 Mar; 98(3):657-668. PubMed ID: 30446805
[TBL] [Abstract][Full Text] [Related]
10. Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.
Tasian SK; Hunger SP
Br J Haematol; 2017 Mar; 176(6):867-882. PubMed ID: 27984637
[TBL] [Abstract][Full Text] [Related]
11. Insights of Acute Lymphoblastic Leukemia with Development of Genomic Investigation.
Xu H; Shu Y
Methods Mol Biol; 2018; 1754():387-413. PubMed ID: 29536454
[TBL] [Abstract][Full Text] [Related]
12. [Recurrent SPI1 fusions in pediatric T-cell acute lymphoblastic leukemia: novel mutations with poor prognosis].
Seki M; Takita J
Rinsho Ketsueki; 2018; 59(4):439-447. PubMed ID: 29743405
[TBL] [Abstract][Full Text] [Related]
13. Detection of recurrent, rare, and novel gene fusions in patients with acute leukemia using next-generation sequencing approaches.
Kim B; Kim E; Lee ST; Cheong JW; Lyu CJ; Min YH; Choi JR
Hematol Oncol; 2020 Feb; 38(1):82-88. PubMed ID: 31875988
[TBL] [Abstract][Full Text] [Related]
14. The biology of relapsed acute lymphoblastic leukemia: opportunities for therapeutic interventions.
Bhatla T; Jones CL; Meyer JA; Vitanza NA; Raetz EA; Carroll WL
J Pediatr Hematol Oncol; 2014 Aug; 36(6):413-8. PubMed ID: 24942023
[TBL] [Abstract][Full Text] [Related]
15. Treatment and biology of pediatric acute lymphoblastic leukemia.
Kato M; Manabe A
Pediatr Int; 2018 Jan; 60(1):4-12. PubMed ID: 29143423
[TBL] [Abstract][Full Text] [Related]
16. [Molecular mechanisms of pediatric intractable leukemia].
Takita J
Rinsho Ketsueki; 2023; 64(8):810-815. PubMed ID: 37673635
[TBL] [Abstract][Full Text] [Related]
17. Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia.
Seki M; Kimura S; Isobe T; Yoshida K; Ueno H; Nakajima-Takagi Y; Wang C; Lin L; Kon A; Suzuki H; Shiozawa Y; Kataoka K; Fujii Y; Shiraishi Y; Chiba K; Tanaka H; Shimamura T; Masuda K; Kawamoto H; Ohki K; Kato M; Arakawa Y; Koh K; Hanada R; Moritake H; Akiyama M; Kobayashi R; Deguchi T; Hashii Y; Imamura T; Sato A; Kiyokawa N; Oka A; Hayashi Y; Takagi M; Manabe A; Ohara A; Horibe K; Sanada M; Iwama A; Mano H; Miyano S; Ogawa S; Takita J
Nat Genet; 2017 Aug; 49(8):1274-1281. PubMed ID: 28671687
[TBL] [Abstract][Full Text] [Related]
18. Genome wide association studies for treatment-related adverse effects of pediatric acute lymphoblastic leukemia.
Franca R; Zudeh G; Lucafò M; Rabusin M; Decorti G; Stocco G
WIREs Mech Dis; 2021 May; 13(3):e1509. PubMed ID: 33016644
[TBL] [Abstract][Full Text] [Related]
19. [Pediatric acute lymphoblastic leukemia: update on pathophysiology and management].
Kato M
Rinsho Ketsueki; 2018; 59(5):504-510. PubMed ID: 29877240
[TBL] [Abstract][Full Text] [Related]
20. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.
Fernández-Navarro P; López-Nieva P; Piñeiro-Yañez E; Carreño-Tarragona G; Martinez-López J; Sánchez Pérez R; Aroca Á; Al-Shahrour F; Cobos-Fernández MÁ; Fernández-Piqueras J
BMC Cancer; 2019 Oct; 19(1):1005. PubMed ID: 31655559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
